ES2181586B1 - Producto farmaceutico para el tratamiento de tumores cancerigenos. - Google Patents
Producto farmaceutico para el tratamiento de tumores cancerigenos.Info
- Publication number
- ES2181586B1 ES2181586B1 ES200101007A ES200101007A ES2181586B1 ES 2181586 B1 ES2181586 B1 ES 2181586B1 ES 200101007 A ES200101007 A ES 200101007A ES 200101007 A ES200101007 A ES 200101007A ES 2181586 B1 ES2181586 B1 ES 2181586B1
- Authority
- ES
- Spain
- Prior art keywords
- pharmaceutical product
- treatment
- tumors
- cancerigene
- ground
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
- 229940127557 pharmaceutical product Drugs 0.000 title abstract 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- IWOUKMZUPDVPGQ-UHFFFAOYSA-N barium nitrate Chemical compound [Ba+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O IWOUKMZUPDVPGQ-UHFFFAOYSA-N 0.000 abstract 2
- UBXAKNTVXQMEAG-UHFFFAOYSA-L strontium sulfate Chemical compound [Sr+2].[O-]S([O-])(=O)=O UBXAKNTVXQMEAG-UHFFFAOYSA-L 0.000 abstract 2
- QHAASGKUXNPGQO-UHFFFAOYSA-L [Mg+2].[Fe+2].[O-]C([O-])=O Chemical compound [Mg+2].[Fe+2].[O-]C([O-])=O QHAASGKUXNPGQO-UHFFFAOYSA-L 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 229910052878 cordierite Inorganic materials 0.000 abstract 1
- JSKIRARMQDRGJZ-UHFFFAOYSA-N dimagnesium dioxido-bis[(1-oxido-3-oxo-2,4,6,8,9-pentaoxa-1,3-disila-5,7-dialuminabicyclo[3.3.1]nonan-7-yl)oxy]silane Chemical compound [Mg++].[Mg++].[O-][Si]([O-])(O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2)O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2 JSKIRARMQDRGJZ-UHFFFAOYSA-N 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Producto farmacéutico para el tratamiento de tumores cancerígenos. Este producto farmacéutico incluye en su composición: sulfato de estroncio entre el 30 y 35%, nitrato de bario entre el 30 y 35%, cordierita molida entre el 15 y 20%, pistomesita molida entre 15 y 20% y glicerina entre el 0,1 y 2%; correspondiendo los porcentajes expresados a cantidades en volumen.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200101007A ES2181586B1 (es) | 2001-05-03 | 2001-05-03 | Producto farmaceutico para el tratamiento de tumores cancerigenos. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200101007A ES2181586B1 (es) | 2001-05-03 | 2001-05-03 | Producto farmaceutico para el tratamiento de tumores cancerigenos. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2181586A1 ES2181586A1 (es) | 2003-02-16 |
| ES2181586B1 true ES2181586B1 (es) | 2004-06-16 |
Family
ID=8497597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES200101007A Expired - Fee Related ES2181586B1 (es) | 2001-05-03 | 2001-05-03 | Producto farmaceutico para el tratamiento de tumores cancerigenos. |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2181586B1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014044756A1 (en) * | 2012-09-20 | 2014-03-27 | Mokwalo SA | Strontium as anti microbial compound |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4979935A (en) * | 1989-02-21 | 1990-12-25 | Quantex Corporation | Method of photodynamic therapy employing electron trapping material |
| EP0513442A1 (fr) * | 1991-05-16 | 1992-11-19 | Romuald Dr. Kowalski | Composition contenant du sulfate de barium pour le traitement des hémorroides |
| FR2740341B1 (fr) * | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau |
| US6294678B1 (en) * | 1997-01-14 | 2001-09-25 | George P. Sakalosky | Treatment for cancer and compounds for use therewith |
-
2001
- 2001-05-03 ES ES200101007A patent/ES2181586B1/es not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2181586A1 (es) | 2003-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0119249D0 (en) | Organic compounds | |
| HK1079519A1 (en) | Furyl compounds | |
| GEP20053692B (en) | Substituted Alkylamine Derivatives and Methods of Use | |
| GB0022438D0 (en) | Organic Compounds | |
| DE60203260D1 (de) | Pharmazeutische mischung gegen krebs, die ein 4-chinazolinamin in kombination mit paclitaxel, carboplatin or vinorelbine enthält | |
| AR012172A2 (es) | Composiciones farmaceuticas que comprenden analogos de lactacistina y uso de los mismos para la fabricacion de un medicamento | |
| CA2301057A1 (en) | A method of administering liposomal encapsulated taxane | |
| ES2178724T3 (es) | Acidos arilsulfonamido hidroxamicos alfa-sustituidos como inhibidores de factor de necrosis tumoral alfa y de metaloproteinasas de matriz. | |
| AR027355A1 (es) | Acidos tiazolidincarboxilicos | |
| MXPA05011208A (es) | Uso de ivermectina para el tratamiento de desordenes dermatologicos. | |
| EP1591112A4 (en) | INHIBITOR OF BREAST CANCER RESISTANT PROTEIN | |
| HK1076812A1 (en) | Cyanoguanidine prodrugs | |
| TW200510392A (en) | Chemical compounds | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| ATE401875T1 (de) | Pharmazeutische feste dispersionen von modafinil- verbindungen | |
| ATE500216T1 (de) | Tricyclische derivate oder pharmazeutisch unnbedenkliche salze davon, deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
| ZA200500908B (en) | Ruthenium anticancer complexes | |
| HRPK20041072B3 (en) | Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer | |
| TW200505452A (en) | Chemical compounds | |
| AR043071A1 (es) | Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica | |
| EP1503748A4 (en) | DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY | |
| ES2116612T3 (es) | Nuevas bis-naftalimidas para el tratamiento del cancer. | |
| PT1718651E (pt) | Derivados 7h-pirrolopirimidina | |
| ATE363909T1 (de) | Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten | |
| ES2181586B1 (es) | Producto farmaceutico para el tratamiento de tumores cancerigenos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 20030216 Kind code of ref document: A1 |
|
| FG2A | Definitive protection |
Ref document number: 2181586B1 Country of ref document: ES |
|
| FD1A | Patent lapsed |
Effective date: 20100312 |